Jyong Biotech Ltd. Ordinary Shares
Status: Publicly traded
Direct answer
Jyong Biotech Ltd. Ordinary Shares is publicly traded on NASDAQ under the ticker MENS.
Jyong Biotech Ltd. is a Taiwanese biotechnology enterprise dedicated to the research, development, and market introduction of botanical therapeutics, specifically aimed at addressing diseases of the urinary system. Its operations are orchestrated through various subsidiary entities, including Health Ever Bio-Tech and Genvace. The company is actively advancing a robust pipeline of drug candidates, which notably...
Can you invest in Jyong Biotech Ltd. Ordinary Shares?
Yes. Jyong Biotech Ltd. Ordinary Shares trades publicly on NASDAQ as MENS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Jyong Biotech Ltd. Ordinary Shares
Detailed equity research is provided by MarketSnap.